132 related articles for article (PubMed ID: 20218967)
1. 3D-QSAR Studies on a Series of 5-Arylidine-2, 4-Thiazolidinediones as Aldose Reductase Inhibitors: A Self-Organizing Molecular Field Analysis Approach.
Thareja S; Aggarwal S; Bhardwaj TR; Kumar M
Med Chem; 2010 Mar; ():. PubMed ID: 20218967
[TBL] [Abstract][Full Text] [Related]
2. 3D-QSAR studies on a series of 5-arylidine-2, 4-thiazolidinediones as aldose reductase inhibitors: a self-organizing molecular field analysis approach.
Thareja S; Aggarwal S; Bhardwaj TR; Kumar M
Med Chem; 2010 Jan; 6(1):30-6. PubMed ID: 20402658
[TBL] [Abstract][Full Text] [Related]
3. 3D-QSAR studies on unsaturated 4-azasteroids as human 5alpha-reductase inhibitors: a self organizing molecular field analysis approach.
Aggarwal S; Thareja S; Bhardwaj TR; Kumar M
Eur J Med Chem; 2010 Feb; 45(2):476-81. PubMed ID: 19906465
[TBL] [Abstract][Full Text] [Related]
4. Self organizing molecular field analysis on a series of human 5alpha-reductase inhibitors: unsaturated 3-carboxysteroid.
Thareja S; Aggarwal S; Bhardwaj TR; Kumar M
Eur J Med Chem; 2009 Dec; 44(12):4920-5. PubMed ID: 19716209
[TBL] [Abstract][Full Text] [Related]
5. 3D-QSAR studies on a series of 2,4-thiazolidinedione derivatives: a self- organizing molecular field analysis approach to design novel PTP 1B inhibitors.
Malla P; Kumar M
Med Chem; 2013 Sep; 9(6):828-45. PubMed ID: 22974292
[TBL] [Abstract][Full Text] [Related]
6. Quantitative structure-activity analysis of 5-arylidene-2,4-thiazolidinediones as aldose reductase inhibitors.
Sambasivarao SV; Soni LK; Gupta AK; Hanumantharao P; Kaskhedikar SG
Bioorg Med Chem Lett; 2006 Feb; 16(3):512-20. PubMed ID: 16297625
[TBL] [Abstract][Full Text] [Related]
7. Self-organizing molecular field analysis on pregnane derivatives as human steroidal 5alpha-reductase inhibitors.
Aggarwal S; Thareja S; Bhardwaj TR; Kumar M
Steroids; 2010 Jun; 75(6):411-8. PubMed ID: 20170668
[TBL] [Abstract][Full Text] [Related]
8. Cheminformatics based 3D-QSAR study on a series of 1,2-naphthoquinone derivatives as PTP 1B inhibitors.
Pahwa P; Papreja M
Acta Pol Pharm; 2012; 69(3):535-43. PubMed ID: 22594268
[TBL] [Abstract][Full Text] [Related]
9. A comprehension on structure guided alignment dependent 3D-QSAR modelling, and molecular dynamics simulation on 2,4-thiazolidinediones as aldose reductase inhibitors for the management of diabetic complications.
Gautam P; Bisht P; Gautam A; Gupta GD; Singh R; Verma SK
J Biomol Struct Dyn; 2023 Oct; ():1-20. PubMed ID: 37904329
[TBL] [Abstract][Full Text] [Related]
10. 3D-QSAR studies on a series of dihydroorotate dehydrogenase inhibitors: analogues of the active metabolite of leflunomide.
Li SL; He MY; Du HG
Int J Mol Sci; 2011; 12(5):2982-93. PubMed ID: 21686163
[TBL] [Abstract][Full Text] [Related]
11. Validation of TZD Scaffold as Potential ARIs: Pharmacophore Modeling, Atom-based 3D QSAR and Docking Studies.
Dahiya L; Mahapatra MK; Kaur R; Kumar V; Kumar M
Comb Chem High Throughput Screen; 2017; 20(4):310-320. PubMed ID: 28302016
[TBL] [Abstract][Full Text] [Related]
12. Self-organizing molecular field analysis of 2,4-thiazolidinediones: A 3D-QSAR model for the development of human PTP1B inhibitors.
Thareja S; Aggarwal S; Bhardwaj TR; Kumar M
Eur J Med Chem; 2010 Jun; 45(6):2537-46. PubMed ID: 20236737
[TBL] [Abstract][Full Text] [Related]
13. Combined 3D-QSAR modeling and molecular docking study on multi-acting quinazoline derivatives as HER2 kinase inhibitors.
Mirzaie S; Monajjemi M; Hakhamaneshi MS; Fathi F; Jamalan M
EXCLI J; 2013; 12():130-43. PubMed ID: 26417222
[TBL] [Abstract][Full Text] [Related]
14. In vitro aldose reductase inhibitory activity of some flavonyl-2,4-thiazolidinediones.
Daş-Evcimen N; Bozdağ-Dündar O; Sarikaya M; Ertan R
J Enzyme Inhib Med Chem; 2008 Jun; 23(3):297-301. PubMed ID: 18569331
[TBL] [Abstract][Full Text] [Related]
15. Assessment of biological half life using in silico QSPkR approach: a self organizing molecular field analysis (SOMFA) on a series of antimicrobial quinolone drugs.
Goel H; Sinha VR; Thareja S; Aggarwal S; Kumar M
Int J Pharm; 2011 Aug; 415(1-2):158-63. PubMed ID: 21664443
[TBL] [Abstract][Full Text] [Related]
16. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS
Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501
[TBL] [Abstract][Full Text] [Related]
17. Quinoxalinones Based Aldose Reductase Inhibitors: 2D and 3D-QSAR Analysis.
Masand VH; Elsayed NN; Thakur SD; Gawhale N; Rathore MM
Mol Inform; 2019 Aug; 38(8-9):e1800149. PubMed ID: 31131980
[TBL] [Abstract][Full Text] [Related]
18. 3d QSAR studies on a series of quinazoline derrivatives as tyrosine kinase (egfr) inhibitor: the k-nearest neighbor molecular field analysis approach.
Noolvi MN; Patel HM
J Basic Clin Pharm; 2010 Jun; 1(3):153-75. PubMed ID: 24825983
[TBL] [Abstract][Full Text] [Related]
19. Rhodanine-3-acetamide derivatives as aldose and aldehyde reductase inhibitors to treat diabetic complications: synthesis, biological evaluation, molecular docking and simulation studies.
Bacha MM; Nadeem H; Zaib S; Sarwar S; Imran A; Rahman SU; Ali HS; Arif M; Iqbal J
BMC Chem; 2021 Apr; 15(1):28. PubMed ID: 33906691
[TBL] [Abstract][Full Text] [Related]
20. Structure-Activity Relationship Study Reveals Benzazepine Derivatives of Luteolin as New Aldose Reductase Inhibitors for Diabetic Cataract.
Sebastian J
Curr Drug Discov Technol; 2016; 13(3):152-163. PubMed ID: 27396410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
